Rachel Page

Rachel Page has over 20 years of work experience in various leadership roles in the clinical and pharmaceutical industries.

Rachel is currently serving as the Chief Commercial Officer (CCO) at Veristat, a position they have held since October 2023. Prior to this, they were a Member at Chief, starting in March 2022.

From September 2022 to October 2023, Rachel worked as the Chief Commercial Officer (CCO) at CTI Clinical Trial and Consulting Services.

Prior to their roles as CCO, they held several positions at Clario from 2015 to 2022. These include Exec (Group) VP, Strategic and Global CRO Commercial Team, Global Vice President, Strategic Global Business Development Team, VP, Global CRO Team, and European Head Business Development, Partnerships. In these roles, they were responsible for leading teams, enhancing partnerships, generating revenue, and strengthening innovation.

Rachel also has experience as a Senior Director at ICON plc (Docs) from 2012 to 2014, and as the Managing Director at Max Resourcing LTD and Aston Executive LTD from 2008 to 2012.

Rachel started their career at Quintiles (Royce Consultancy) as a National Sales Director and National Account Director from 2002 to 2008, and also worked at Elan Computing and Eurolink earlier in their career.

Overall, Rachel Page has a strong background in leadership, commercial strategy, business development, and partnership management in the clinical and pharmaceutical industries.

Rachel Page attended Belfast High School from 1983 to 1990. Rachel then went on to study at Edinburgh Napier University from 1991 to 1995, where they obtained a BSc HONS in Social and Management Sciences.